Viridian Therapeutics Correlations

VRDN Stock  USD 15.46  0.20  1.31%   
The current 90-days correlation between Viridian Therapeutics and Day One Biopharmaceuticals is 0.23 (i.e., Modest diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Viridian Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Viridian Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Viridian Therapeutics Correlation With Market

Average diversification

The correlation between Viridian Therapeutics and DJI is 0.17 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Viridian Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Viridian Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
To learn how to invest in Viridian Stock, please use our How to Invest in Viridian Therapeutics guide.

Moving together with Viridian Stock

  0.73CDIOW Cardio DiagnosticsPairCorr
  0.79ELVN Enliven TherapeuticsPairCorr
  0.85SCLX Scilex HoldingPairCorr
  0.81ASMB Assembly Biosciences Earnings Call This WeekPairCorr
  0.61CDIO Cardio DiagnosticsPairCorr
  0.79CRNX Crinetics PharmaceuticalsPairCorr
  0.67CAT CaterpillarPairCorr
  0.79MSFT Microsoft Aggressive PushPairCorr

Moving against Viridian Stock

  0.84LUCD Lucid DiagnosticsPairCorr
  0.77WM Waste ManagementPairCorr
  0.58GE GE AerospacePairCorr
  0.42PLX Protalix BiotherapeuticsPairCorr
  0.41PG Procter GamblePairCorr
  0.84JNJ Johnson Johnson Sell-off TrendPairCorr
  0.81T ATT Inc Sell-off TrendPairCorr
  0.69CVX Chevron CorpPairCorr
  0.64CSCO Cisco SystemsPairCorr
  0.63INTC Intel Sell-off TrendPairCorr
  0.61XOM Exxon Mobil Corp Earnings Call Next WeekPairCorr
  0.58IBM International BusinessPairCorr
  0.57MMM 3M CompanyPairCorr
  0.41DD Dupont De NemoursPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
RVMDRCKT
PLRXRCKT
RCKTDAWN
PLRXQURE
RVMDDAWN
QURERCKT
  
High negative correlations   
PTGXDAWN
PTGXRCKT
RVMDPTGX
PLRXPTGX
PLRXMIRM
QUREMIRM

Risk-Adjusted Indicators

There is a big difference between Viridian Stock performing well and Viridian Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Viridian Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
DAWN  2.87 (0.52) 0.00 (0.64) 0.00 
 6.36 
 22.86 
REPL  2.83 (0.06) 0.00 (0.11) 0.00 
 5.86 
 22.75 
MIRM  1.87  0.25  0.11  0.16  1.99 
 5.32 
 13.96 
RCKT  2.70 (0.41) 0.00 (0.41) 0.00 
 4.92 
 12.71 
RNA  2.83  0.07  0.00 (0.02) 0.00 
 6.64 
 20.15 
QURE  3.96  0.09  0.00 (0.02) 0.00 
 7.02 
 30.10 
PTGX  2.79  0.42  0.22 (0.35) 2.47 
 3.48 
 50.66 
PLRX  6.35 (1.80) 0.00 (0.61) 0.00 
 10.39 
 80.84 
IMCR  2.10  0.11  0.05  0.14  2.55 
 5.34 
 10.97 
RVMD  1.71 (0.16) 0.00 (0.20) 0.00 
 4.37 
 11.35 

Viridian Therapeutics Corporate Management

Seth HarmonPrincipal AccountingProfile
Anthony CasicanoChief OfficerProfile
Kristian MBAChief CFOProfile
Melissa MannoChief OfficerProfile
Anthony CascianoChief OfficerProfile
Jennifer JDChief OfficerProfile